http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20030025926-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4706 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4706 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-06 |
| filingDate | 2000-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2003-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20030025926-A |
| titleOfInvention | A combination kit used in the treatment of malaria |
| abstract | Antimalarial agent 3- [1-[[4-[(6-methoxy-8-quinolinyl) amino] pentyl] amino] ethylidene] -dihydro-2 (3H) furanone in capsule form in separate dosages (I); Antimalarial chloroquine in discrete dosage forms; And a combination kit for treating malaria caused by trichophytomegaly including instructions for administering the two antimalarial drugs. The combination kit is particularly suitable for 6-day treatments, wherein the treatment is 5 tablets containing 500 mg of chloroquine phosphate and 25 mg of 3- [1-[[4-[(6-methoxy-8-qui) 5 capsules containing nolinyl) amino] pentyl] amino] ethylidene] -dihydro-2 (3H) furanone (I), three tablets are administered on day 1 and from days 2 to One tablet each is administered on day 3 and one capsule each on days 2-6. |
| priorityDate | 2000-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 67.